QT Vascular is a Singapore-incorporated company focused on designing advanced therapeutic solutions for the treatment of complex vascular disease. TriReme Medical, Inc, TriReme Medical (Singapore) Pte, Ltd and Quattro Vascular Pte, Ltd are wholly-owned subsidiaries of QT Vascular Ltd and were co-founded by CEO Eitan Konstantino, Ph.D.

Incorporated in 2005, TriReme Medical initially developed the Antares, a dedicated stent for the treatment of bifurcations. Over time, TriReme developed and launched Glider™, GliderXtreme™ and GliderfleX®, all aimed at assisting physicians in the treatment of complex vascular lesions.

Quattro Vascular was incorporated in 2010 to support the development of Chocolate® – the first interventional medical device developed in Singapore to receive FDA approval.